Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim

ClinicalTrials.gov ID: NCT01752907

Public ClinicalTrials.gov record NCT01752907. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 11:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Single-blind Study to Estimate the Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim

Study identification

NCT ID
NCT01752907
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Amgen
Industry
Enrollment
304 participants

Conditions and interventions

Conditions

Interventions

  • General Education DVD Other
  • Bone Pain Education DVD Other

Other

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 16, 2013
Primary completion
Dec 14, 2014
Completion
Dec 14, 2014
Last update posted
Nov 28, 2022

2013 – 2014

United States locations

U.S. sites
51
U.S. states
25
U.S. cities
51
Facility City State ZIP Site status
Research Site Fountain Valley California 92708
Research Site Mission Hills California 91345
Research Site Santa Rosa California 95403
Research Site Vallejo California 94589
Research Site Whittier California 90603
Research Site Danbury Connecticut 06810
Research Site Greenwich Connecticut 06830
Research Site Fort Lauderdale Florida 33308
Research Site Chicago Illinois 60616
Research Site Elk Grove Village Illinois 60007
Research Site Naperville Illinois 60540
Research Site Peoria Illinois 61615
Research Site Cedar Rapids Iowa 52403
Research Site Mason City Iowa 50401
Research Site Mount Sterling Kentucky 40353
Research Site Lewiston Maine 04240
Research Site Boston Massachusetts 02135
Research Site Fairhaven Massachusetts 02719
Research Site Lansing Michigan 48912
Research Site Robbinsdale Minnesota 55422
Research Site Saint Louis Park Minnesota 55426
Research Site Jefferson City Missouri 65109
Research Site St Louis Missouri 63136
Research Site Omaha Nebraska 68106
Research Site Portsmouth New Hampshire 03801
Research Site Englewood New Jersey 07631
Research Site Hamilton New Jersey 08650
Research Site Morristown New Jersey 07960
Research Site Vineland New Jersey 08360
Research Site Albuquerque New Mexico 87109-4397
Research Site Cooperstown New York 13326
Research Site Glens Falls New York 12801
Research Site Poughkeepsie New York 12601
Research Site Suffern New York 10901
Research Site Asheboro North Carolina 27203
Research Site Charlotte North Carolina 28204
Research Site Fayetteville North Carolina 28304
Research Site Goldsboro North Carolina 27534
Research Site Hendersonville North Carolina 28791
Research Site Canton Ohio 44708
Research Site Massillon Ohio 44646
Research Site Middletown Ohio 45042
Research Site Bend Oregon 97701
Research Site Gettysburg Pennsylvania 17325
Research Site Langhorne Pennsylvania 19047
Research Site Aberdeen South Dakota 57401
Research Site Sioux Falls South Dakota 57105
Research Site Bristol Tennessee 37620
Research Site El Paso Texas 79905
Research Site Danville Virginia 24541
Research Site Burien Washington 98166

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01752907, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 28, 2022 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01752907 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →